BMC microbiology

Peritoneal dialysis is linked to increased microbial production of sesquiterpene and triterpene compounds in patients with end-stage kidney disease

Updated

Abstract

Shotgun metagenomic sequencing of fecal samples revealed increased complexity in gut microbiota interactions among patients undergoing for end-stage renal disease.

  • Gut microbiota interactions in patients receiving peritoneal dialysis are more complex compared to those not receiving dialysis.
  • Increased aggregation characteristics of gut microbiota interactions were observed in patients undergoing peritoneal dialysis.
  • The gut microbiota in peritoneal dialysis patients may drive the production of specific compounds, such as sesquiterpenes and triterpenes.
  • These compounds could be linked to enhanced blood purification and improved circulation in patients receiving dialysis.

Simplified

Key numbers

18
Participants
11 ESRD_N patients and 7 ESRD_P patients were included.
83
Differential Microbial Species
Relative abundance changes were analyzed between ESRD_N and ESRD_P groups.
12
Significantly Changed KEGG Pathways
These pathways were linked to microbial gene changes in ESRD_P patients.

Full Text

We can’t show the full text here under this license.

Funding

Competing interests

The authors declare no competing interests.
PubMed

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free